A39.50 Meningococcal carditis, unspecified

Name of the Condition

• Meningococcal carditis, unspecified

Summary

Meningococcal carditis, unspecified, is a rare complication of Neisseria meningitidis infection involving inflammation or damage to the heart. It may occur as part of systemic meningococcal disease and can present with cardiac symptoms or findings. Prompt recognition and treatment are essential to manage cardiac involvement and prevent further complications.

Causes

Meningococcal carditis, unspecified, is caused by Neisseria meningitidis, a bacterium that spreads through respiratory droplets or direct contact with infected secretions. The infection may lead to myocarditis (inflammation of the heart muscle), pericarditis (inflammation of the pericardium), or endocarditis (infection of the heart valves), typically as a result of bacteremia or septicemia.

Risk Factors

• Meningococcal infection (especially with certain serogroups).
• Underlying immunocompromised states or asplenia.
• Lack of vaccination against meningococcal disease.
• Close contact with an infected individual.
• Severe or prolonged meningococcal septicemia.

Symptoms

• Chest pain or discomfort.
• Shortness of breath.
• Palpitations or irregular heartbeat.
• Fatigue or weakness.
• Fever (if active infection persists).
• Signs of heart failure (e.g., swelling in legs, fluid retention).

Diagnosis

Diagnosis involves clinical evaluation and laboratory testing. Blood cultures may identify Neisseria meningitidis. Cardiac imaging (e.g., echocardiography) can assess heart structure and function. Electrocardiography (ECG) may reveal abnormalities consistent with myocarditis or pericarditis. Lumbar puncture may be performed if meningitis is suspected.

Treatment Options

Treatment focuses on eradicating the infection and managing cardiac symptoms. Antibiotics (e.g., ceftriaxone, penicillin) are administered to target Neisseria meningitidis. Supportive care may include medications for heart failure, anti-inflammatory drugs for pericarditis, or rhythm management for arrhythmias. Hospitalization is often required for monitoring and intensive care.

Prognosis and Follow-Up

Prognosis depends on the severity of cardiac involvement and timeliness of treatment. Early intervention improves outcomes, but severe cases may lead to long-term cardiac damage or failure. Follow-up care includes monitoring heart function through imaging or ECG, and addressing any residual symptoms or complications.

Complications

• Heart failure (acute or chronic).
• Arrhythmias (irregular heartbeats).
• Pericardial effusion or tamponade.
• Persistent myocardial dysfunction.
• Recurrent infection or sepsis.

Lifestyle & Prevention

• Vaccination against meningococcal disease (e.g., MenACWY, MenB) is the most effective preventive measure.
• Avoid close contact with infected individuals during outbreaks.
• Practice good hygiene (e.g., handwashing) to reduce transmission risk.
• Seek prompt medical care for symptoms of meningococcal infection.

When to Seek Professional Help

Seek immediate medical attention if you experience sudden chest pain, severe shortness of breath, palpitations, or signs of heart failure (e.g., swelling, fatigue). These symptoms may indicate acute cardiac involvement requiring urgent evaluation and treatment.

Tips for Medical Coders

Document the clinical findings supporting cardiac involvement (e.g., imaging, ECG results) and specify whether the carditis is acute or chronic if known. Ensure the diagnosis aligns with the unspecified nature of the code, and avoid specifying cardiac structure (e.g., myocarditis, pericarditis) unless documented. Code A39.50 is appropriate when the carditis is not further specified.